Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Raphael Gourevitch is active.

Publication


Featured researches published by Raphael Gourevitch.


Encephale-revue De Psychiatrie Clinique Biologique Et Therapeutique | 2009

Risque d’homicide et troubles mentaux graves : revue critique de la littérature

S. Richard-Devantoy; Jean-Pierre Olié; Raphael Gourevitch

INTRODUCTION Tragic and high profile killings by people with mental illness have been used to suggest that the community care model for mental health services has failed. It is also generally thought that schizophrenia predisposes subjects to homicidal behaviour. OBJECTIVE The aim of the present paper was to estimate the rate of mental disorder in people convicted of homicide and to examine the relationship between definitions. We investigated the links between homicide and major mental disorders. METHODS This paper reviews studies on the epidemiology of homicide committed by mentally disordered people, taken from recent international academic literature. The studies included were identified as part of a wider systematic review of the epidemiology of offending combined with mental disorder. The main databases searched were Medline. A comprehensive search was made for studies published since 1990. RESULTS There is an association of homicide with mental disorder, most particularly with certain manifestations of schizophrenia, antisocial personality disorder and drug or alcohol abuse. However, it is not clear why some patients behave violently and others do not. Studies of people convicted of homicide have used different definitions of mental disorder. According to the definition of Hodgins, only 15% of murderers have a major mental disorder (schizophrenia, paranoia, melancholia). Mental disorder increases the risk of homicidal violence by two-fold in men and six-fold in women. Schizophrenia increases the risk of violence by six to 10-fold in men and eight to 10-fold in women. Schizophrenia without alcoholism increased the odds ratio more than seven-fold; schizophrenia with coexisting alcoholism more than 17-fold in men. We wish to emphasize that all patients with schizophrenia should not be considered to be violent, although there are minor subgroups of schizophrenic patients in whom the risk of violence may be remarkably high. According to studies, we estimated that this increase in risk could be associated with a paranoid form of schizophrenia and coexisting substance abuse. The prevalence of schizophrenia in the homicide offenders is around 6%. Despite this, the prevalence of personality disorder or of alcohol abuse/dependence is higher: 10% to 38% respectively. The disorders with the most substantially higher odds ratios were alcohol abuse/dependence and antisocial personality disorder. Antisocial personality disorder increases the risk over 10-fold in men and over 50-fold in women. Affective disorders, anxiety disorders, dysthymia and mental retardation do not elevate the risk. Hence, according to the DMS-IV, 30 to 70% of murderers have a mental disorder of grade I or a personality disorder of grade II. However, many studies have suffered from methodological weaknesses notably since obtaining comprehensive study groups of homicide offenders has been difficult. CONCLUSIONS There is an association of homicide with mental disorder, particularly with certain manifestations of schizophrenia, antisocial personality disorder and drug or alcohol abuse. Most perpetrators with a history of mental disorder were not acutely ill or under mental healthcare at the time of the offence. Homicidal behaviour in a country with a relatively low crime rate appears to be statistically associated with some specific mental disorders, classified according to the DSM-IV-TR classifications.


Psychiatry Research-neuroimaging | 2010

Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders.

Maryse Lévy-Rueff; Raphael Gourevitch; H. Lôo; Jean-Pierre Olié; Isabelle Amado

This retrospective chart review of a clinical cohort of 19 refractory schizophrenic or schizoaffective patients treated with maintenance electroconvulsive therapy addresses the indications for this treatment, its efficacy, and its impact on daily functioning and hospitalizations. Maintenance electroconvulsive therapy combined with medication appears to be an efficient alternative to pharmacological treatment alone.


Encephale-revue De Psychiatrie Clinique Biologique Et Therapeutique | 2008

Folie à deux : actualités d’un concept ancien, à propos de deux cas

Sabine Mouchet-Mages; Raphael Gourevitch; H. Lôo

INTRODUCTION Folie à deux or induced delusional disorder is a rare mental disorder. It was initially described by the French Lasègue and Falret in 1877. Two subjects, who live in a close relationship, in isolation, share delusional ideas based on the same themes. Various classifications exist. Its epidemiology remains unclear, because most of the data have been extrapolated from case reports. CASE REPORTS In this paper, we describe and comment two cases of shared paranoid disorder: in the first case report, a husband shares the paranoiac delusion of his wife; the second case report describes a shared paranoid disorder between a schizophrenic daughter and her mother. LITERATURE FINDINGS A review of the existing literature is also presented. Some clinical characteristics arise, such as frequent mother-daughter associations and diagnosis of schizophrenia in inducing subject. Particular social and psychopathological conditions for the occurrence of a shared delusional disorder are described, such as personality traits and genetic influences. This article also reviews some forensic issues, which may be of importance, since this disorder is underdiagnosed. Data concerning the principles of its treatment are sparse, but most authors consider that the separation of the two subjects has to be the basis of any intervention. The inducing subject has to be treated with specific medical interventions, including the prescription of antipsychotics. Sometimes, the separation is enough to eliminate the delusional ideas from the induced subject, who, according to the ICD-10 and DSM-IV, is the only one to meet the criteria for shared delusional disorder. The case reports are discussed in light of the review, and some propositions for their treatment are made. CONCLUSION As shared delusional disorder is a rare disease, only few data exist on its pathophysiology and mechanisms, and controlled studies are needed in order to understand its specific implications better and to define recommendations for its management.


Pharmacogenomics | 2011

Association of an UCP4 (SLC25A27) haplotype with ultra-resistant schizophrenia.

Fayçal Mouaffak; Oussama Kebir; Alfredo Bellon; Raphael Gourevitch; Sylvie Tordjman; Annie Viala; Bruno Millet; Nematollah Jaafari; Jean Pierre Olie; Marie Odile Krebs

AIMS Neuronal uncoupling proteins are involved in the regulation of reactive oxygen species production and intracellular calcium homeostasis, and thus, play a neuroprotective role. In order to explore the potential consequences of neuronal uncoupling proteins variants we examined their association in a sample of Caucasian patients suffering from schizophrenia and phenotyped them according to antipsychotic response. MATERIALS & METHODS Using a case-control design, we compared the frequencies of 15 genetic variants spanning UCP2, UCP4 and UCP5 in 106 French Caucasian patients suffering from schizophrenia and 127 healthy controls. In addition, patients with schizophrenia who responded to antipsychotic treatment were compared with patients with ultra-resistant schizophrenia (URS). This latter population presented no clinical, social and/or occupational remission despite at least two periods of treatment with conventional or atypical antipsychotic drugs and also with clozapine. RESULTS There were no differences in the distribution of the respective alleles between URS and responding patients. However, one haplotype spanning UCP4 was found to be significantly under-represented in URS patients. This relationship remained significant after multiple testing corrections. CONCLUSION Although our sample is of limited size and not representative of schizophrenia as a whole, the association found between the URS group and the UCP4 haplotype is noteworthy as it may influence treatment outcome in schizophrenia.


Clinical Neuropharmacology | 2006

Somatic augmentation strategies in clozapine resistance--what facts?

Constantin Tranulis; Fayçal Mouaffak; Laurent Chouchana; Emmanuel Stip; Raphael Gourevitch; Jean-Pierre Olié; Henri Lôo; David Gourion

Background: Polypharmacy without evidence-based support is sometimes needed for patients treated with 40% to 70% clozapine who are clozapine nonresponders. Several somatic augmentation strategies are proposed in the scientific literature, with different levels of evidence for safety and efficacy. Objectives: The purpose of the present study is to review the available literature on the efficacy and safety of clozapine augmentation with somatic agents other than antipsychotics. The following classes of agents are considered: (1) mood stabilizers, (2) antidepressants, (3) electroconvulsive therapy and repetitive transcranial magnetic stimulation, (4) glutamatergic agents, (5)fatty acids supplements, and (6) benzodiazepines. Results: Case controls and small-size clinical trials largely dominate the literature, limiting the power to draw conclusions concerning safety issues and the meaning of negative studies. Moreover, variable definitions of clozapine resistance, heterogeneous outcome measures, and short duration of treatment trials are additional limitations. Conclusion: Generally, adjunctive strategies for clozapine-resistant patients remain based on scarce evidence of efficacy and significant safety concerns. Low-frequency repetitive transcranial magnetic stimulation, fatty acids supplements, and mirtazapine showed good tolerability and some efficacy, but the results need replication.


Journal of Forensic and Legal Medicine | 2016

Major mental disorders, gender, and criminological circumstances of homicide

S. Richard-Devantoy; Anne-Isabelle Bouyer-Richard; Cédric Annweiler; Raphael Gourevitch; Fabrice Jollant; Jean-Pierre Olié; Marie-Chantal Bourdel; Jean-Paul Lhuillier; Olivier Beauchet

OBJECTIVE To examine the criminological circumstances of homicide in a group of French murderers with and without major mental disorders (MMD) stratified by the perpetrators gender. METHODS Sociodemographic, clinical, and criminological variables were collected from the psychiatric expert reports of 210 cases of homicide heard at the High Court of Angers, France. Murderers were categorized according to MMD diagnosis and gender. RESULTS Among 210 murderers, 17.6% (n = 37) had a MMD (20% of the female perpetrators). Logistic regression models showed that being a murderer with a MMD was associated with younger age (adjusted Odds Ratio OR = 1.03, P = 0.034), high school education (OR = 2.48, P = 0.036), previous use of psychiatric services (OR = 4.75, P = 0.003), alcohol intoxication (OR = 2.71, P = 0.027), and delusional state (OR = 3.96, P = 0.002) at the time of the homicide. Multiple correspondence analyses showed that female murderers with a MMD were more prone to have depression and to use drowning as a method than those without a MMD, and that male murderers with a MMD more often had a high school education and delusional beliefs at the time of the homicide than those without a MMD. CONCLUSION Specific profiles of criminological circumstances of homicide could help to explore the risk of homicide in female and male patients with a MMD.


Clinical Neuropharmacology | 2006

Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.

Fayçal Mouaffak; Constantin Tranulis; Raphael Gourevitch; Marie-France Poirier; Saida Douki; Jean-Pierre Olié; Henri Lôo; David Gourion


Schizophrenia Research | 2008

PERI-PUBERTAL MATURATION AFTER DEVELOPMENTAL DISTURBANCE: A MODEL FOR PSYCHOSIS ONSET IN THE RAT

Gwenaëlle Le Pen; Franck Hazane; Raphael Gourevitch; Thérèse-Marie Jay; Marie-Odile Krebs


Encephale-revue De Psychiatrie Clinique Biologique Et Therapeutique | 2008

Folie deux: actualits dun concept ancien, propos de deux cas

Sabine Mouchet-Mages; Raphael Gourevitch; H. Lôo


/data/revues/00137006/00300002/109/ | 2008

L'hypothèse neurodéveloppementale dans la schizophrénie

David Gourion; Raphael Gourevitch; J B Le Provost; Jean Pierre Olie; H. Lôo; Marie Odile Krebs

Collaboration


Dive into the Raphael Gourevitch's collaboration.

Top Co-Authors

Avatar

H. Lôo

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Jean-Pierre Olié

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Richard-Devantoy

Douglas Mental Health University Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anne-Isabelle Bouyer-Richard

Institut Philippe Pinel de Montréal

View shared research outputs
Top Co-Authors

Avatar

Emmanuel Stip

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

Fabrice Jollant

Douglas Mental Health University Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge